<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref11">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bernstein</surname>
    <given-names>D. I.</given-names>
   </name>
   <name>
    <surname>Guptill</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Naficy</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Nachbagauer</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Berlanda-Scorza</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Feser</surname>
    <given-names>J.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2019</year>). 
  <article-title>Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial</article-title>. 
  <source>Lancet Infect. Dis.</source>
  <volume>20</volume>, 
  <fpage>80</fpage>â€“
  <lpage>92</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S1473-3099(19)30393-7</pub-id>
  <pub-id pub-id-type="pmid">31630990</pub-id>
 </mixed-citation>
</ref>
